Table 2.

Facilitators to the adoption of telemedicine to manage chronic obstructive pulmonary disease (COPD).

Facilitators	Articles	Occurrence (N=56), n (%)
Improved patient outcomes or satisfaction	[8,9,16,17,24,29-31,36,38,40]	13 (23)
Reduced need for in-person visits	[8,9,16,17,22,30,32,35,36]	9 (16)
Better disease management	[8,17,22,28,30,31,34,40]	8 (14)
Bolstered patient-provider relationship	[20,21,23,24,30]	5 (9)
High-quality data	[16,19,25,28]	4 (7)
Patient empowerment	[8,17,21,23]	4 (7)
Ease of use	[17,25,32]	3 (5)
Predictability of exacerbations	[9,19,25]	3 (5)
Provision of additional services	[30,32,41]	3 (5)
Patient engagement	[16,17]	2 (4)
Access to patient data	[16]	1 (2)
Communication	[22]	1 (2)